Market News

NASDAQ | TSX: ACB

 Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and full fiscal year 2022 on Tuesday, September 20, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the fourth quarter and full fiscal year 2022 after the close of markets that same day.

Aurora Cannabis Logo (CNW Group/Aurora Cannabis Inc.)

Conference Call Details

DATE:

Tuesday, September 20, 2022

TIME:

5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time

WEBCAST:

Click here

Miguel Martin , Chief Executive Officer, and Glen Ibbott , Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://investor.auroramj.com/ under "News & Events".

Additionally, Aurora has announced that along with the filing of its annual financial statements, it expects to file other annual disclosure documents – including the Annual Information Form. Furthermore, Aurora announced that it has scheduled its Annual General and Special Meeting of shareholders, which will be held virtually on Monday, November 14, 2022 at 1 p.m. Eastern Time | 11:00 a.m. Mountain Time . In conjunction with the meeting, Aurora expects to file its Information Circular and related proxy materials, which will be available for download under its profile on both SEDAR and EDGAR.

About Aurora

Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Aurora Drift , San Rafael '71 , Daily Special , Whistler , Being and Greybeard , as well as CBD brands, Reliva and KG7 . Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. Aurora also has a controlling interest in Bevo Farms , North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn .

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index.

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include statements regarding timing of the release of the Company's financial statements for fourth quarter ended June 30, 2022 and associated conference call, as well as timing for our Annual General and Special Meeting and filing of related proxy materials.

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions managements considers to be reasonable.  Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer  sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated September 27, 2021 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC's website at www.sec.gov . The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-fourth-quarter-and-full-fiscal-year-2022-investor-conference-call-and-related-year-end-informational-filings-301614031.html

SOURCE Aurora Cannabis Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2022/29/c7494.html

News Provided by Canada Newswire via QuoteMedia

ACB:CA,ACB
TSXV:FLWR

The Flowr Corporation Among Top Sellers in Ontario

The Flowr Corporation (TSXV:FLWR) was recently featured in an article analyzing sales data for Ontario cannabis companies on the Ontario cannabis store (OCS) during the first two weeks of legalization.

The OCS is an online sales platform and is the only legal place to acquire recreational cannabis in the province of Ontario. The top sellers in the province were Aurora Cannabis (TSX:ACB; NYSE:ACB), responsible for 24 percent of sales, and RedeCan Pharm, with 26 percent of sales. The next four companies ranged between five and ten percent of sales, and included Emblem Corp. (TSXV:EMC,OTCQX:EMMBF), Canopy Growth (TSX:WEED,NYSE:CGC), VIVO Cannabis and Flowr, which was responsible for six percent of sales in the province.

Keep reading...Show less
TSXV:FLWR

The Flowr Corporation Goes Public on the TSXV

The Flowr Corporation (TSXV:FLWR) has announced that it will commence trading today, September 26, on the TSX Venture Exchange under the ticker symbol FLWR.

The company was recently featured in a Forbes article, where the publication addressed the company’s work leading up to the listing. In anticipation of today’s news, the company raised $27 million and took part in a reverse takeover. According to Flowr CEO Vinay Tolia, they will use the momentum from the listing to “focus on executing [their] business plan.”

Keep reading...Show less
TSXV:LABS

OCS Announces New Supply Agreements with Additional Licensed Producers and Accessory Suppliers

The Ontario Cannabis Store (OCS) is dedicated to providing safe and responsible access to recreational cannabis through its online store once it’s legal on October 17. In preparation for October, the OCS has been establishing its wholesale distribution network so they can provide a broad selection of cannabis products in their legal and privately run stores once Ontario puts its regulations in place.

This week the OCS announced that they have signed six more agreements with licensed producers, bringing their total to 32 licensed producers and 10 accessory suppliers. Of the licensed producers signed, MediPharm Labs Inc. was one of them. MediPharm Labs is a leading B2B Canadian cannabis extractor that produces pharma-grade cannabis oil and concentrates for cannabinoid derived products. Their state-of-the-art facility can currently process 100,000 kilograms of dry cannabis per year and the company plans on increasing its capacity to over 250,000 kilograms per year by Q4 2018. MediPharm Labs has secured a steady supply of cannabis to process from several licensed producers including the James E. Wagner Cultivation Corporation (TSXV:JWCA) and 6779264 Manitoba Ltd. (O/A Bonify).

Keep reading...Show less

Trulieve Opens New Medical Cannabis Dispensary in Milton, West Virginia

Grand opening celebration event on Sept. 24

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the grand opening of its newest West Virginia dispensary in Milton at 5 Perry Morris Square. The Milton dispensary will open its doors on Sept. 24 at 10 a.m. EDT for patients, with ongoing hours of 10 a.m. to 8 p.m. from Monday through Saturday, and 10 a.m. to 6 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Opens New Medical Cannabis Dispensary in Belle, West Virginia

Grand opening celebration event on Sept. 24

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the grand opening of its newest West Virginia dispensary in Belle at 2700 Dupont Ave Suite 9. The Belle dispensary will open its doors on Sept. 24 at 10 a.m. EDT for patients, with ongoing hours of 10 a.m. to 8 p.m. from Monday through Saturday, and 10 a.m. to 6 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

TerrAscend Appoints Karim Bouaziz as President of the Northeast Region

September 22, 2022 CNW TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF a leading North American cannabis operator, today announced the appointment of Karim Bouaziz as President of the Northeast region. Karim brings nearly 6 years of experience in the cannabis industry, starting as Co-Founder and SVP of Operations & Retail with VidaCann, before taking the role as a Regional President at Parallel.

Prior to joining the cannabis industry, Karim held key finance and operational leadership roles in both private and publicly traded companies across varying industries, including Newell Brands , United Technologies, and the Walt Disney Company.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Wins Georgia Production License to Provide Patients Access Statewide to Medical Cannabis

Company expands Southeast Hub with Class 1 license in Georgia

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the Georgia Access to Medical Cannabis Commission ("GMCC" or "Commission") awarded Trulieve GA, Inc. with a Class 1 production license. Trulieve patients in Georgia will be able to choose from a variety of low-THC oil products in both oral and topical forms in the near future.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Announces Opening of Relocated Edgewater Dispensary in Florida

New dispensary expands patient access to medical cannabis; grand opening specials available

9 p.m. from Monday through Saturday and 10 a.m8 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Centurion Announces Conditional Acceptance of Casa Berardi West Gold Project Transaction; Resumption of Trading

Centurion Minerals Ltd. (TSXV: CTN) (the "Company" or "Centurion") is pleased to announce that, further to its news release dated August 8, 2022, the TSX Venture Exchange (the "TSX-V") has conditionally accepted the previously announced Option Agreement that provides Centurion with the right to earn a 100% interest in the Casa Berardi West Gold Project (the "Project"). The Project is located in the prolific gold-producing, Harricana-Turgeon greenstone belt of the central Abitibi Subprovince of north-eastern Ontario. A NI 43-101 technical report entitled "NI 43-101 Independent Technical Report on the Casa Berardi West Properties, Cochrane, Ontario" having an effective date of June 30, 2022 has now been filed on SEDAR under Centurion's profile and can be viewed on Centurion's website.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×